Products in Development for U.S.
MyCare Psychiatry
- Olanzapine
- Paliperidone
- Quetiapine
- Aripiprazole
- Risperidone
Our antipsychotic assays provide objective information, and when used in combination with other clinical information, may help you make better-informed treatment decisions and enhance shared decision making between you and your patient.
Olanzapine‡
Antipsychotic Product Performance
| Assay Range ng / mL | Within-Laboratory Precision, %CV | Method Comparison to LC-MS/MS | ||||
| Low Control | Medium Control | High Control | Slope | Intercept | Correlation Coefficient | |
| 22 – 114 | 4.6 | 1.9 | 3.7 | 1.038 | -0.1 | 0.98 |
Recommended therapeutic reference ranges, laboratory alert levels and levels of recommendation for therapeutic drug monitoring*
| Level | Therapeutic reference range (ng/mL) | Laboratory alert level (ng/mL) |
| 1 | 20 – 80 | 100 |
Paliperidone‡
Antipsychotic Product Performance
| Assay Range ng / mL | Within-Laboratory Precision, %CV | Method Comparison to LC-MS/MS | ||||
| Low Control | Medium Control | High Control | Slope | Intercept | Correlation Coefficient | |
| 16 – 120 | 3.7 | 2.7 | 3.3 | 1.00 | 2.86 | 0.94 |
Recommended therapeutic reference ranges, laboratory alert levels and levels of recommendation for therapeutic drug monitoring*
| Level | Therapeutic reference range (ng/mL) | Laboratory alert level (ng/mL) |
| 2 | 20 – 60 | 120 |
Quetiapine‡
Antipsychotic Product Performance
| Assay Range ng / mL | Within-Laboratory Precision, %CV | Method Comparison to LC-MS/MS | ||||
| Low Control | Medium Control | High Control | Slope | Intercept | Correlation Coefficient | |
| 34 – 700 | 7.4 | 3.7 | 3.7 | 1.03 | 13.55 | 0.92 |
Recommended therapeutic reference ranges, laboratory alert levels and levels of recommendation for therapeutic drug monitoring*
| Level | Therapeutic reference range (ng/mL) | Laboratory alert level (ng/mL) |
| 2 | 20 – 60 | 120 |
Aripiprazole‡
Antipsychotic Product Performance
| Assay Range ng / mL | Within-Laboratory Precision, %CV | Method Comparison to LC-MS/MS | ||||
| Low Control | Medium Control | High Control | Slope | Intercept | Correlation Coefficient | |
| 45 – 1000 | 8.3 | 4.0 | 3.9 | 1.01 | 2.56 | 0.98 |
Recommended therapeutic reference ranges, laboratory alert levels and levels of recommendation for therapeutic drug monitoring*
| Level | Therapeutic reference range (ng/mL) | Laboratory alert level (ng/mL) |
| 2 | 150 – 500 | 1000 |
Risperidone‡
Antipsychotic Product Performance
| Assay Range ng / mL | Within-Laboratory Precision, %CV | Method Comparison to LC-MS/MS | ||||
| Low Control | Medium Control | High Control | Slope | Intercept | Correlation Coefficient | |
| 16 – 120 | 3.7 | 2.8 | 3.3 | 0.98 | 1.23 | 0.96 |
Recommended therapeutic reference ranges, laboratory alert levels and levels of recommendation for therapeutic drug monitoring*
| Level | Therapeutic reference range (ng/mL) | Laboratory alert level (ng/mL) |
| 2 | 20 – 60 | 120 |
Request Information
If you are interested in ordering a test kit, please contact our USA headquarters via the contact information below, or fill out the contact form.
USA Headquarters
116 Research Drive,
Bethlehem, PA 18015
+1 (610) 419-6731
